Clinical Context
A typical patient is a reproductive-age woman seen in an outpatient clinic for contraception management or treatment of dysfunctional uterine bleeding. The clinician prescribes depot medroxyprogesterone acetate (DMPA) injectable progestin and administers J1050 (Injection, medroxyprogesterone acetate, 1 mg) as an intramuscular or subcutaneous injection in the clinic setting. The workflow: patient check-in and medication reconciliation; informed consent and counseling on side effects; confirmation of pregnancy status if clinically indicated; preparation and administration of the injection (usually gluteal or deltoid intramuscular, or subcutaneous for certain formulations); observation for immediate adverse reaction (5–15 minutes); documentation of lot number, dose, route, site, and manufacturer in the medical record; and scheduling of follow-up or next injection. Typical settings include outpatient primary care, family planning clinics, obstetrics-gynecology offices, community health centers, and publicly funded contraceptive clinics. Medicare, Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and BUCA payors may cover this service per benefit rules and medical necessity criteria.